Geopolitics Alpha

8-K - Summit Therapeutics Inc. (0001599298) (Filer)

Published . Updated .

Key takeaways

  • 8-K - Summit Therapeutics filed an 8-K with the SEC on Nov 16 (a notice of a material company event).
  • Exposed: SMMT, XLV, LLY, JNJ, ABBV
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHA8-K - Summit Therapeutics Inc.(0001599298) (Filer)SMMTGEOPOLITICS ALPHA

8-K - Summit Therapeutics filed an 8-K with the SEC on Nov 16 (a notice of a material company event).

Directly affected

  • SMMT Summit Therapeutics

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Summit Therapeutics belongs to, so it often moves with news about it.

  • LLY Eli Lilly and

    Eli Lilly and is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • JNJ Johnson & Johnson

    Johnson & Johnson is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • ABBV AbbVie

    AbbVie is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • MRK Merck

    Merck is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • ABT Abbott Laboratories

    Abbott Laboratories is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
SMMT+26.12%+17.57%baseafter closeafter closeafter closeafter close
XLV-0.28%+0.04%baseafter closeafter closeafter closeafter close
LLY-2.25%-0.49%baseafter closeafter closeafter closeafter close
JNJ-1.35%-1.97%baseafter closeafter closeafter closeafter close
ABBV-0.57%-0.04%baseafter closeafter closeafter closeafter close
MRK+0.65%-0.38%baseafter closeafter closeafter closeafter close
ABT+1.85%+0.80%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-16 AccNo: 0001599298-26-000092 Size: 1 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Source: sec-edgar

How far Summit Therapeutics (SMMT) has moved since 16 Nov 2026

CompanyWhenMoveStatus
AbbVie (ABBV)three days earlier-0.04%final price
AbbVie (ABBV)five days earlier-0.57%final price
Abbott Laboratories (ABT)three days earlier+0.80%final price
Abbott Laboratories (ABT)five days earlier+1.85%final price
Johnson & Johnson (JNJ)three days earlier-1.97%final price
Johnson & Johnson (JNJ)five days earlier-1.35%final price
Eli Lilly (LLY)three days earlier-0.49%final price
Eli Lilly (LLY)five days earlier-2.25%final price
Merck (MRK)three days earlier-0.38%final price
Merck (MRK)five days earlier+0.65%final price
Summit Therapeutics (SMMT)three days earlier+17.57%final price
Summit Therapeutics (SMMT)five days earlier+26.12%final price
Select Sector Spdr Tr (XLV)three days earlier+0.04%final price
Select Sector Spdr Tr (XLV)five days earlier-0.28%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Summit Therapeutics (SMMT)

Companies carried with this story

  • SMMT Summit Therapeutics

    Summit Therapeutics (SMMT) is linked, with no stored direction, high confidence in the 16 Nov 2026 story “8-K - Summit Therapeutics Inc. (0001599298) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> SMMT

  • XLV Select Sector Spdr Tr

    Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Summit Therapeutics Inc. (0001599298) (Filer).” Reason on file: Health Care Select Sector SPDR holds the health sector that Summit Therapeutics belongs to, so it often moves with news about it

  • LLY Eli Lilly

    Eli Lilly (LLY) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Summit Therapeutics Inc. (0001599298) (Filer).” Reason on file: Eli Lilly and is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news

  • JNJ Johnson & Johnson

    Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Summit Therapeutics Inc. (0001599298) (Filer).” Reason on file: Johnson & Johnson is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news

  • ABBV AbbVie

    In “8-K - Summit Therapeutics Inc. (0001599298) (Filer),” AbbVie (ABBV) is linked, with no stored direction, medium confidence. Reason on file: AbbVie is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news

  • MRK Merck

    In “8-K - Summit Therapeutics Inc. (0001599298) (Filer),” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news

  • ABT Abbott Laboratories

    Abbott Laboratories (ABT) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Summit Therapeutics Inc. (0001599298) (Filer).” Reason on file: Abbott Laboratories is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news

How “8-K - Summit Therapeutics Inc. (0001599298) (Filer)” reaches Summit Therapeutics (SMMT)

The 16 Nov 2026 story “8-K - Summit Therapeutics Inc. (0001599298) (Filer)” names Summit Therapeutics (SMMT) because of this story.

Summit Therapeutics (SMMT) is on the page because SEC 8-K filing -> direct issuer disclosure -> SMMT

Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR holds the health sector that Summit Therapeutics belongs to, so it often moves with news about it

Price levels for Summit Therapeutics (SMMT)

LLY traded between 1239.21 and 1458.90 across 20 sessions. The latest close on file is 1430.09. SMMT traded between 14.17 and 18.14 across 8 sessions. The latest close on file is 15.07.

How strong the case is around Summit Therapeutics (SMMT)

46 out of 100

“8-K - Summit Therapeutics Inc. (0001599298) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.